A possible mechanism explaining the co-occurrence of IFN type I and IL-17/Th17 immune pathway in SLE could be that both IFN type I and production of IL-6 and IL-23 by DCs are regulated through IRF-5 [38,39]. Here, IRF5 is linked to systemic lupus erythematosus.